Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02551510
Other study ID # 4164-07/14
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2015
Est. completion date May 2019

Study information

Verified date March 2020
Source Jena University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Port Wound Closure compares synthetic tissue adhesives with seam for cutaneous wound closure to port plant in terms of cosmetic results and time savings at comparable risk for wound infection.


Description:

Study patients who undergo a subcutaneous venous port implant procedure are randomized into control group (conventional sutures) or into interventional group (synthetic tissue adhesive). The intervention time is documented. Follow-up visit is performed 8 weeks after port implantation. It includes a photo documentation, quality of life questionnaire (EQ5D) and pain scala questionnaire (POSAS) by patient and by 3 independent observers as well as the documentation of complications.


Recruitment information / eligibility

Status Completed
Enrollment 128
Est. completion date May 2019
Est. primary completion date March 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Medical indication for port catheter implantation because of chemotherapy or parenteral nutrition

Exclusion Criteria:

- Children and adolescents < 18 years

- Thrombocytes < 50/nl

- PTT <50%

- INR >1.5

- Systemic or local infection of the interventional location

- Known allergy to used material

- Known allergy to Histoacryl, Cyanoacrylate, D&C Violett or Formaldehyd

- General contraindication of port catheter implantation

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Suture
Skin incision closure with standard subcuticular technique
Device:
Experimental: Histoacryl®
Skin incision closure with topic skin adhesive Histoacryl® Flexible (n-Butyl-2-Cyanoacrylate Monomer)

Locations

Country Name City State
Germany University Hospital Jena Jena Thuringia

Sponsors (2)

Lead Sponsor Collaborator
Jena University Hospital Aesculap AG

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cosmetic outcome after wound healing Wound assessment by 3 independent evaluators (surgeons) and patient himself based on photo documentation 8 weeks
Primary Cosmetic outcome after wound healing Patient and observer scar assessment scale (POSAS) 8 weeks
Primary Cosmetic outcome after wound healing Life quality questionnaire EQ5D 8 weeks
Secondary Infection rate Assessment of adverse events through AE documentation based on the adverse impact of surgical site infections (German: CDC Kriterien) 8 weeks
Secondary Economy of time for wound closure Time measurement by stopwatch and exact documentation of intervention time of subcutaneous suture and skin closure time 10 minutes